Latest / Decera Clinical Education Oncology Podcast
Experts Discuss CELMoD Agents for Multiple Myeloma
In this podcast episode, Meletios-Athanasios (Thanos) C. Dimopoulos, MD, and María-Victoria Mateos, MD, PhD, as they discuss the use of CELMoD agents to manage multiple myeloma, including:
The recent FDA approval of iberdomide
Mechanism of action and differentiation from IMiDs
Current data and potential treatment settings
Presenters:
Meletios-Athanasios (Thanos) C. Dimopoulos, MD
Professor and Chairman
Plasma Cell Dyscrasias Unit
Section of Hematology and Medical Oncology
Department of Clinical Therapeutics
School of Medicine
National and Kapodistrian University of Athens
Alexandra Hospital…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.